United States Gene Expression Analysis Market Forecast to Grow at a CAGR of Around 11.6%, Driven by Advances in Genomic Technologies and Increasing Precision Medicine Adoption | DataM Intelligence

Leander, Texas and TOKYO, Japan - The United States gene expression analysis market was valued at approximately US$ 4.91 billion in 2024 and is expected to reach US$ 13.60 billion by 2034, growing at a CAGR of around 11.6% during the forecast period 2024-2034.

The growth in this market is primarily driven by increasing investments in pharmaceutical and biotechnology research, rising demand for personalized medicine, advancements in gene sequencing technologies, and growing prevalence of chronic diseases such as cancer and neurological disorders.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- http://datamintelligence.com/download-sample/gene-expression-analysis-market?ram

Industry Latest News 2025:

✅ Thermo Fisher Scientific launched the Ion Torrent Genexus System in 2025, offering fully automated, rapid gene expression analysis for clinical and research applications, improving throughput and accuracy.

✅ Illumina introduced the NovaSeq X Series in mid-2025, enhancing high-throughput sequencing with AI-driven data analysis, enabling deeper insight into gene expression profiles for precision medicine.

✅ Bio-Rad Laboratories expanded its droplet digital PCR platforms in 2025, allowing more sensitive and precise quantification of gene expression for oncology and infectious disease research.

✅ Recent developments feature integration of single-cell RNA sequencing and spatial transcriptomics technologies, advancing cellular-level gene expression studies for disease mechanism understanding.

✅ Key trends emphasize growth in personalized medicine, multi-omics data integration, AI-powered analytics, and expansion of gene expression use in drug discovery and clinical diagnostics in the US market.

Merges and Acquisitions (2025):

✅ Thermo Fisher Scientific expanded its gene expression analysis portfolio in 2025 through acquisition of a biotechnology firm specializing in single-cell RNA sequencing technologies, enhancing its capabilities in both Japan and the US markets.

✅ Illumina Inc. strengthened its US and Japan presence with strategic partnerships and acquisitions focusing on spatial transcriptomics and AI-driven gene expression analysis software in 2025, aiming to advance precision medicine and diagnostics.

✅ Bio-Rad Laboratories increased its footprint in Japan and the US by acquiring a molecular diagnostics startup with innovative microarray and qPCR solutions in 2025, accelerating access to next-generation gene expression technologies.

Growth Drivers:

-Increasing demand for personalized medicine and targeted therapies drives the adoption of gene expression analysis to identify unique genetic signatures for more precise treatments.

-Technological advancements, especially high-throughput sequencing tools like next-generation sequencing (NGS) and single-cell RNA sequencing (scRNA-Seq), enable comprehensive and detailed gene expression profiling, expanding research and clinical applications.

-Growing investments by pharmaceutical and biotechnology companies in genomics and drug discovery accelerate demand for gene expression analysis tools to develop new drugs and biomarkers.

-Rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and genetic disorders fuels research into gene expression patterns to understand disease mechanisms and improve diagnostics.

-Emerging research areas, including spatial transcriptomics and epigenomics, broaden the scope of gene expression analysis beyond traditional RNA profiling, enhancing disease understanding and therapeutic strategies.

-Increasing application in clinical diagnostics, drug development, biomedical research, and agriculture supports market expansion.

-Government funding and favorable regulatory frameworks support genomics research and commercialization of gene expression-based diagnostics and therapeutics.

-Growing focus on immunotherapy research and integration with systems biology approaches enhances market demand.

-North America leads market growth, supported by advanced healthcare infrastructure, research funding, and presence of key industry players, while Asia-Pacific is the fastest-growing region due to rising biotech startups and healthcare investments.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=gene-expression-analysis-market?ram (Purchase 2 or more Reports and get 50% Discount)

Market Segmentation Analysis:

-By Product Type

Instruments: Devices and equipment used for gene expression analysis

Services: Analytical, sequencing, and data interpretation services

Others: Consumables, reagents, and software solutions

-By Technique

RNA Expression: Measuring RNA to understand gene activity

Promoter Analysis: Studying DNA regions regulating gene expression

Protein Expression & Post-Translational Modification: Analyzing protein levels and modifications

Others: Additional specialized molecular techniques

-By Application

Drug Discovery & Development: Identifying targets and evaluating drug effects

Clinical Diagnostics: Disease diagnosis and prognosis using gene expression profiles

Biotechnology & Microbiology: Microbial gene studies and industrial biotech applications

Others: Research, agriculture, environmental studies

-By End User

Biotechnology & Pharmaceutical Companies: Develop therapies and diagnostics

Diagnostic Laboratories: Perform clinical tests and validations

Academic Research Centers: Basic and applied research institutions

Contract Research Organizations: Outsourced research and development services

Key Regional Insights:

North America: The region dominates due to strong investments in genomics research, advanced sequencing technologies, and a robust biopharmaceutical ecosystem. The United States and Canada lead with widespread adoption in clinical diagnostics, precision medicine, and drug discovery. Favorable government policies and established research infrastructure further drive market growth.

Europe: Increasing research funding, growing focus on personalized medicine, and supportive regulatory frameworks propel Europe's gene expression analysis market. Key countries include Germany, the UK, and France, with strong contributions from academic institutions and CROs.

Asia-Pacific: This region is the fastest-growing market due to expanding biotechnology research, rising healthcare expenditure, and improving infrastructure. China, Japan, and India are major contributors, boosted by increasing adoption of high-throughput sequencing and gene expression profiling in clinical and academic settings.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/download-sample/gene-expression-analysis-market?ram

Competitive Landscape:

According to DataM Intelligence, the United States Gene Expression Analysis Market is robustly growing, driven by technological advancements in sequencing and analysis platforms, strong research funding, and increasing adoption of precision medicine.

Key Players:
QIAGEN | Merck KGaA | GenScript Biotech Corporation | Bio-Rad Laboratories | Takara Bio Inc.

Key Highlights (Top 5 Key Players) for United States Gene Expression Analysis Market:

-QIAGEN leads with advanced sample and assay technologies enabling efficient and accurate gene expression profiling across research and clinical applications.

-Merck KGaA holds a significant share leveraging its broad portfolio in molecular diagnostics and life science research tools widely used in gene expression studies.

-GenScript Biotech Corporation focuses on providing custom gene synthesis and high-throughput gene expression solutions supporting pharmaceutical and biotech industries.

-Bio-Rad Laboratories, a major player, delivers innovative qPCR and digital PCR platforms essential for precise quantification of gene expression.

-Takara Bio Inc. specializes in enzyme-based technologies and next-generation sequencing reagents fueling enhanced gene expression analysis capabilities.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.